Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

On January 26, 2023, the Board of Directors (the "Board") of Walgreens Boots Alliance, Inc. (the "Company"), upon the recommendation of the Board's Nominating and Governance Committee, approved and adopted, effective immediately, the Company's Amended and Restated Bylaws (as amended and restated, the "Bylaws"). The amendments to the Bylaws include: (a) modifications to the provisions relating to the availability of lists of stockholders entitled to vote at stockholder meetings in Article II, Section 2.6 to reflect recent amendments to the Delaware General Corporation Law (the "DGCL"); (b) revisions to Article II, Section 2.8 to require that any stockholder directly or indirectly soliciting proxies from other stockholders use a proxy card color other than white; (c) revisions to Article II, Sections 2.15, 2.16 and 2.17 with respect to the notification and other requirements related to nominations of directors and solicitations of proxies, including requiring compliance with Rule 14a-19 under the Securities Exchange Act of 1934, as amended, and requiring that stockholder nominees for director provide specified information and sit for interviews with the Board and its committees, if requested; (d) modifications to Article II, Section 2.18 to provide that abstentions and directions to withhold authority will not be considered votes cast in determining the outcome of any election of directors; (e) inclusion of a new Section 3.14 in Article III allowing the Board and committees of the Board to conduct business in the event of an emergency as permitted under the DGCL, and (f) other technical, ministerial, clarifying and conforming changes.

The foregoing summary of the amendments to the Company's Bylaws is qualified in all respects by reference to the text of the Bylaws, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 5.07. Submission of Matters to a Vote of Security Holders.

(a) The Company held its Annual Meeting on January 26, 2023.

(b) Set forth below are the voting results for each of the proposals submitted to a vote of the Company's stockholders at the Annual Meeting:

Proposal No. 1: The stockholders voted for the election of the following directors to serve on the Board until the next Annual Meeting of Stockholders or until their successors are elected and qualified (or any such director's earlier death, resignation or removal):



                                            Votes                             Broker
                         Votes For         Against        Abstentions        Non-Votes
Janice M. Babiak         622,276,609        9,080,379        1,592,400       111,155,434
Inderpal S. Bhandari     625,620,829        5,483,849        1,844,710       111,155,434
Rosalind G. Brewer       622,191,606        9,118,030        1,639,752       111,155,434
Ginger L. Graham         605,098,862       26,244,952        1,605,574       111,155,434
Bryan C. Hanson          621,865,913        9,450,283        1,633,192       111,155,434
Valerie B. Jarrett       610,461,150       21,018,256        1,469,982       111,155,434
John A. Lederer          614,689,631       16,624,470        1,635,287       111,155,434
Dominic P. Murphy        624,122,642        7,108,801        1,717,945       111,155,434
Stefano Pessina          613,517,812       17,700,774        1,730,802       111,155,434
Nancy M. Schlichting     592,861,750       38,355,706        1,731,932       111,155,434

Proposal No. 2: The proposal to approve, on an advisory basis, the compensation of the Company's named executive officers, as set forth in the proxy statement for the Annual Meeting, was approved. There were 555,423,218 votes for, 73,571,554 votes against, and 3,954,616 abstentions. There were 111,155,434 broker non-votes on this proposal.

--------------------------------------------------------------------------------

Proposal No. 3: The proposal to ratify the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for fiscal year 2023 was approved. There were 715,841,987 votes for, 26,216,090 votes against, and 2,046,745 abstentions.

Proposal No. 4: The stockholder proposal requesting report on public health costs due to tobacco product sales and the impact on overall market returns was not approved. There were 64,828,489 votes for, 562,332,664 votes against, and 5,788,235 abstentions. There were 111,155,434 broker non-votes on this proposal.

Proposal No. 5: The stockholder proposal requesting an independent board chairman was not approved. There were 214,178,740 votes for, 416,228,718 votes against, and 2,541,930 abstentions. There were 111,155,434 broker non-votes on this proposal.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits

Exhibit                                     Description

3.1           Amended and Restated Bylaws of Walgreens Boots Alliance, Inc.
104         Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses